Churchill Pharma 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases  1 Product   3 Trials   7 News 
20 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yonsa (abiraterone acetate) / Sun Pharma
OMAHA2a, NCT06136650: A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Recruiting
3
1500
Europe, Japan, US, RoW
Opevesostat, MK-5684, Dexamethasone, Fludrocortisone acetate, Hydrocortisone, Abiraterone acetate, Zytiga, Yonsa, Prednisone acetate, Enzalutamide, Xtandi
Merck Sharp & Dohme LLC, Orion Corporation, Orion Pharma
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
12/30
12/30
OMAHA1, NCT06136624: Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Recruiting
3
1200
Europe, Canada, Japan, US, RoW
Opevesostat, MK-5684, Abiraterone acetate, ZYTIGA, YONSA, Enzalutamide, XTANDI, Hydrocortisone, Fludrocortisone acetate, Prednisone, Dexamethasone
Merck Sharp & Dohme LLC, Orion Corporation, Orion Pharma
Prostate Cancer Metastatic
08/28
08/28
REVELUTION-2, NCT06650579: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Not yet recruiting
3
72
US
Abiraterone Acetate, BR9004, BR9004-1, CB 7630, CB-7630, CB7630, JNJ-212082, Yonsa, Zytiga, Bicalutamide, Casodex, Cassotide, Cosudex, ICI 176,334, ICI 176334, Utamide, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography Angiography, CT ANGIOGRAPHY, CT Scan Angiography, CTA, Leuprolide, Leuprorelin, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Relugolix, N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea, Orgovyx, Relumina, TAK 385, TAK-385, TAK385
Emory University, Pfizer, Sumitomo Pharma America, Inc., National Comprehensive Cancer Network, National Cancer Institute (NCI)
Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC V8, Stage IVA Prostate Cancer AJCC V8
07/29
07/29
NCI-2019-03812, NCT03999515: Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Terminated
2
3
US
Abiraterone Acetate, 154229-18-2, 17-(3-Pyridyl)-5, 16-androstadien-3beta-acetate, Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), CB7630, Yonsa, Zytiga, BR9004, BR9004-1, JNJ-212082, Enzalutamide, 915087-33-1, ASP9785, Benzamide, MDV3100, Xtandi, Erdafitinib, Balversa, JNJ-42756493
University of Washington, Janssen Research & Development, LLC
Castration-Resistant Prostate Carcinoma, Double-Negative Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
06/21
06/21
NCI-2018-01548, NCT03649841: Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Terminated
2
10
US
Antiandrogen Therapy, ADT, Androgen Deprivation Therapy, Androgen Deprivation Therapy (ADT), Anti-androgen Therapy, Anti-androgen Treatment, Antiandrogen Treatment, Hormone Deprivation Therapy, Hormone-Deprivation Therapy, Abiraterone Acetate, 17-(3-Pyridyl)-5,16-androstadien-3beta-acetate, 154229-18-2, Yonsa, Zytiga, Prednisone, 10023, Delta 1-Cortisone, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, NOS, Radiotherapeutics, radiotherapy, RT, ENERGY TYPE
University of Washington, National Cancer Institute (NCI)
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
09/22
02/23
NCT04734730: Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

Recruiting
2
70
US
Abiraterone Acetate, CB7630, Yonsa, Zytiga, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Degarelix, FE200486, Firmagon, Goserelin Acetate, ZDX, Zoladex, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Lutrate, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Questionnaire Administration, Talazoparib, BMN 673, BMN-673
City of Hope Medical Center, National Cancer Institute (NCI)
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
08/27
08/27
NCT04267887: Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Active, not recruiting
2
7
US
Abiraterone Acetate, CB7630, Yonsa, Zytiga, Antiandrogen Therapy, ADT, Androgen Deprivation Therapy, Androgen Deprivation Therapy (ADT), Anti-androgen Therapy, Anti-androgen Treatment, Antiandrogen Treatment, Hormone Deprivation Therapy, Hormone-Deprivation Therapy, Apalutamide, ARN 509, ARN-509, ARN509, Erleada, JNJ 56021927, JNJ-56021927, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized Tomography, CT, CT Scan, Bone Scan, Bone Scintigraphy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Questionnaire Administration
OHSU Knight Cancer Institute, Janssen Scientific Affairs, LLC, Oregon Health and Science University
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
01/28
01/30
NCT06369610: Risk Stratified De-escalated Hormone Therapy with Radiation Therapy for the Treatment Prostate Cancer

Recruiting
2
57
US
Abiraterone Acetate, BR9004, BR9004-1, CB7630, JNJ-212082, Yonsa, Zytiga, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Gonadotropin-releasing Hormone Analog, GnRH Agonist, GnRH Analog, Gonadotropin-Releasing Hormone Agonist, Gonadotropin-Releasing Hormone Analogue, LH-RH agonist, LH-RH Analogs, LHRH Agonist, luteinizing hormone-releasing hormone agonist, Luteinizing Hormone-Releasing Hormone Analog, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Questionnaire Administration, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation
Mayo Clinic
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma
04/27
04/27
NCI-2018-01054, NCT03360721: Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Active, not recruiting
2
7
US
Abiraterone Acetate, CB7630, Yonsa, Zytiga, Apalutamide, ARN 509, ARN-509, ARN509, Erleada, JNJ 56021927, JNJ-56021927, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
04/25
04/25
NCT03821792: Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Active, not recruiting
2
60
US
Abiraterone Acetate, CB7630, Yonsa, Zytiga, Apalutamide, ARN 509, ARN-509, ARN509, Erleada, JNJ 56021927, JNJ-56021927, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
10/26
10/26
NCI-2018-01856, NCT01786265: Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Active, not recruiting
2
310
US
Abiraterone Acetate, CB7630, Yonsa, Zytiga, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Degarelix, FE200486, Firmagon, Flutamide, 4''-Nitro-3''-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, Sch 13521, Tafenil, Tecnoflut, Testotard, Goserelin Acetate, ZDX, Zoladex, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Lutrate, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Nilutamide, Anandron, Nilandron, RU-23908, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone
M.D. Anderson Cancer Center
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma
02/25
02/25
NCT05422911: Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Not yet recruiting
2
200
US
Abiraterone acetate, Apalutamide, Enzalutamide
James J. Peters Veterans Affairs Medical Center
Metastatic Cancer, Neoplasm, Prostate
06/25
06/26
2019-003485-40: ACTION: Abiraterone in Combination with Tildrakizumab

Not yet recruiting
1/2
45
Europe
YONSA, Ilumya, MK-3222, Tablet, Solution for infusion, YONSA, Ilumya
The Institute of Cancer Research
Metastatic castration resistant prostate cancer, Prostate cancer, Diseases [C] - Cancer [C04]
 
 
ACTIon, NCT04458311: Abiraterone Acetate in Combination With Tildrakizumab

Terminated
1/2
13
Europe
Abiraterone Acetate, Yonsa, Tildrakizumab
Institute of Cancer Research, United Kingdom, Sun Pharmaceutical Industries Limited
Metastatic Castration Resistant Prostate Cancer
04/23
11/23
NCT04666129: Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Completed
1
48
US
Relugolix, MVT-601, TAK-385, T-1331285, RVT-601, Orgovyx, Abiraterone, Zytiga, Yonsa, Prednisone, Methylprednisolone, Medrol, Apalutamide, Erleada, Docetaxel, Docefrez, Taxotere
Sumitomo Pharma Switzerland GmbH
Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer
05/24
05/24
NCT05276492: Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

Active, not recruiting
1
50
US
Abiraterone Oral Tablet, Yonsa, Zytiga, Prednisone tablet, Deltasone, Prednicot, Rayos, Sterapred, Sterapred DS, Drug Dairy/Log, Low-fat meal
University of Chicago
Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm, Prostate Cancer Metastatic
07/25
11/25
NCT05520138: Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Completed
N/A
5506
US
Enzalutamide, Xtandi, Abiraterone acetate, Yonsa, Zytiga
Pfizer
Prostatic Neoplasms, Castration-Resistant
06/23
06/23
NCT06151418: A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

Completed
N/A
1000
US
Novel hormonal therapy, Abiraterone(Yonsa, Zytiga), Apalutamide(Erleada), Enzalutamide(Xtandi)
Pfizer, Astellas Pharma Inc
Prostatic Neoplasms
04/24
04/24
NCT05968599: A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Completed
N/A
2733
US
Enzalutamide, Xtandi, Abiraterone acetate, Yonsa, Zytiga
Pfizer, Astellas Pharma Inc
Prostatic Neoplasms, Castration-Resistant
10/24
10/24
NCT06072196: A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Active, not recruiting
N/A
2903
US
Novel hormonal therapy, Abiraterone (Yonsa, Zytiga), Apalutamide (Erleada), Enzalutamide (Xtandi)
Pfizer, Astellas Pharma Inc
Prostatic Neoplasms
01/25
01/25

Download Options